195 related articles for article (PubMed ID: 2560285)
1. [Prevention of thrombosis with unfractionated and low molecular weight heparin].
Breddin HK
Wien Med Wochenschr; 1989 Dec; 139(23):555-9. PubMed ID: 2560285
[TBL] [Abstract][Full Text] [Related]
2. [Potentials risks in drug prevention of thrombosis--low-molecular-weight heparin versus standard heparin].
Ganzer D; Gutezeit A; Mayer G
Z Orthop Ihre Grenzgeb; 1999; 137(5):457-61. PubMed ID: 10549126
[TBL] [Abstract][Full Text] [Related]
3. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
[TBL] [Abstract][Full Text] [Related]
4. [Heparin-induced thrombocytopenia after elective hip joint replacement with postoperative prevention of thromboembolism with low-molecular-weight heparin].
Marx A; Huhle G; Hoffmann U; Wang LC; Schüle B; Jani L; Harenberg J
Z Orthop Ihre Grenzgeb; 1999; 137(6):536-9. PubMed ID: 10666863
[TBL] [Abstract][Full Text] [Related]
5. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
6. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
7. [Prevention of thrombosis in surgery: low molecular weight heparin/standard heparin].
Weinand HA; Gehrke T; Krieg H; Brünner H
Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():1175-7. PubMed ID: 1983508
[TBL] [Abstract][Full Text] [Related]
8. Effects of standard unfractionated and low-molecular-weight heparins on platelets of patients undergoing total hip replacement surgery.
Aulmann M; Kwasniki S; Böttiger BW; Meeder PJ
Beitr Infusionsther Transfusionsmed; 1997; 34():242-7. PubMed ID: 9356680
[TBL] [Abstract][Full Text] [Related]
9. Low molecular weight heparins--state-of-the-art and unsolved issues.
Breddin HK
Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S17-9. PubMed ID: 8180324
[TBL] [Abstract][Full Text] [Related]
10. Prevention of thromboembolic disease in general surgery with enoxaparin (Clexane).
Samama M; Combe S
Acta Chir Scand Suppl; 1990; 556():91-5. PubMed ID: 1963022
[TBL] [Abstract][Full Text] [Related]
11. [Prevention of thromboembolism with low-molecular-weight heparin in ambulatory surgery and unoperated surgical and orthopedic patients].
Harenberg J; Piazolo L; Misselwitz F
Zentralbl Chir; 1998; 123(11):1284-7. PubMed ID: 9880848
[TBL] [Abstract][Full Text] [Related]
12. The role of low molecular weight heparin in total knee arthroplasty.
Iobst CA; Friedman RJ
Am J Knee Surg; 1999; 12(1):55-60. PubMed ID: 10050695
[TBL] [Abstract][Full Text] [Related]
13. Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery.
Bergqvist D
Br J Surg; 2004 Aug; 91(8):965-74. PubMed ID: 15286956
[TBL] [Abstract][Full Text] [Related]
14. [Low molecular weight heparin: favorable effect profile for prevention and therapy of venous thrombosis].
Marbet GA
Ther Umsch; 1992 Dec; 49(12):843-9. PubMed ID: 1336627
[TBL] [Abstract][Full Text] [Related]
15. An overview of clinical trials of low molecular weight heparin fractions.
Levine MN; Hirsh J
Acta Chir Scand Suppl; 1988; 543():73-9. PubMed ID: 2847461
[TBL] [Abstract][Full Text] [Related]
16. [Thromboembolism prophylaxis with low molecular weight heparin in abdominal surgery].
Adolf J; Knee H; Roder JD; van de Flierdt E; Siewert JR
Dtsch Med Wochenschr; 1989 Jan; 114(2):48-53. PubMed ID: 2535983
[TBL] [Abstract][Full Text] [Related]
17. Antithrombotic defense during the postoperative period. Clinical documentation of low molecular weight heparin.
Welzel D; Wolf H; Koppenhagen K
Arzneimittelforschung; 1988 Jan; 38(1):120-3. PubMed ID: 2835055
[TBL] [Abstract][Full Text] [Related]
18. [Prevention of thromboembolism with low molecular weight heparin (Fragmin) in obstetrics].
Krauss T; Rath W; Dittmer U; Kuhn W
Z Geburtshilfe Perinatol; 1994 Aug; 198(4):120-5. PubMed ID: 7975797
[TBL] [Abstract][Full Text] [Related]
19. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism: a review of risk and prevention in colorectal surgery patients.
Bergqvist D
Dis Colon Rectum; 2006 Oct; 49(10):1620-8. PubMed ID: 17019655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
